From Discovery to Therapy: The Rise of Reprogrammed Tregs

Nobel Prize winner Shimon Sakaguchi, a pioneer in regulatory T cell (Treg) biology, discusses the path from early observations to reprogrammed cell therapies for autoimmune disease.